लोड हो रहा है...
Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
PURPOSE: Netarsudil is a Rho kinase/norepinephrine transporter inhibitor currently in phase 3 clinical development for glaucoma treatment. We investigated the effects of its active metabolite, netarsudil-M1, on outflow facility (C), outflow hydrodynamics, and morphology of the conventional outflow p...
में बचाया:
| में प्रकाशित: | Invest Ophthalmol Vis Sci |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
The Association for Research in Vision and Ophthalmology
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5114035/ https://ncbi.nlm.nih.gov/pubmed/27842161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.16-20189 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|